First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation

Diagnostic Microbiology and Infectious Disease

Volumn 62, Issue 3, 2008, Pages 336-339

  Auberger, Jutta ^a   Lass Flörl, Cornelia ^b   Clausen, Johannes ^a   Bellmann, Romuald ^a   Buzina, Walter ^c   Gastl, Günther ^a   Nachbaur, David ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Allogeneic; Aspergillus niveus; Hematopoietic stem cell transplantation; Invasive fungal infection

Indexed keywords

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLUS; ASPERGILLUS NIVEUS; CASE REPORT; CLINICAL FEATURE; FANCONI ANEMIA; FEMALE; FUNGAL STRAIN; FUNGUS IDENTIFICATION; HUMAN; LUNG INFECTION; PRIORITY JOURNAL; SYMPTOM;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; DRUG RESISTANCE, FUNGAL; FANCONI ANEMIA; FATAL OUTCOME; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG DISEASES, FUNGAL; PYRIMIDINES; TRANSPLANTATION, HOMOLOGOUS; TRIAZOLES; YOUNG ADULT;

EID: 54049154633     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.06.012     Document Type: Article

References (24)

1. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert F., Denning D.W., Donnelly J.P., Edwards J.E., Erjavec Z., Fiere D., Lortholary O., Maertens J., Meis J.F., Patterson T.F., Ritter J., Selleslag D., Shah P.M., Stevens D.A., Walsh T.J., and Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34 (2002) 7-14
2. Bedini A., Venturelli C., Mussini C., Guaraldi G., Codeluppi M., Borghi V., Rumpianesi F., Barchiesii F., and Esposito R. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. J. Clin. Microbiol. 12 (2006) 75-80
3. Bille J., Marchetti O., and Calandra T. Changing face of health-care associated fungal infections. Curr. Opin. Infect. Dis. 18 (2005) 314-319
4. Calvo A., Guarro J., Suarez G., and Ramirez C. Air-borne fungi in the air of Barcelona (Spain). III. The genus Aspergillus link. Mycopathologia 71 (1980) 41-43
5. Clinical and Laboratory Standards Institute (2007) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. Document M38-A. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Cornet M., Fleury L., Maslo C., Bernard J.F., Brücker G., and Invasive Aspergillosis Surveillance Network of the Assistance Publique-Hôpitaux de Paris. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J. Hosp. Infect. 51 (2002) 288-296
7. Denning D.W. Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis. 23 (1996) 608-615
8. Herbrecht R., Denning D.W., Patterson T.F., Bennett J.E., Greene R.E., Oestmann J.W., Kern W.V., Marr K.A., Ribaud P., Lortholary O., Sylvester R., Rubin R.H., Wingard J.R., Stark P., Durand C., Caillot D., Thiel E., Chandrasekar P.H., Hodges M.R., Schlamm H.T., Troke P.F., de Pauw B., and Invasive Fungal Infections Cooperative Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 347 (2002) 408-415
9. Iwen P.C., Rupp M.E., Langnas A.N., Reed E.C., and Hinrichs S.H. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin. Infect. Dis. 26 (1998) 1092-1097
10. Lass-Flörl C., and Perkhofer S. In vitro susceptibility-testing in Aspergillus species. Mycoses (2008) (electronic publication ahead of print)
11. Lass-Flörl C., Rath P., Niederwieser D., Kofler G., Würzner R., Krezy A., and Dierich M.P. Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. J. Hosp. Infect. 46 (2000) 31-35
12. Lass-Flörl C., Griff K., Mayr A., Petzer A., Gastl G., Bonatti H., Freund M., Kropshofer G., Dierich M.P., and Nachbaur D. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br. J. Haematol. 131 (2005) 201-207
13. Lass-Flörl C., Resch G., Nachbaur D., Mayr A., Gastl G., Auberger J., Bialek R., and Freund M.C. The value of computed tomography-guided percutaneous lung biopsies in diagnosing invasive fungal infections in immunocompromised patients. Clin. Infect. Dis. 45 (2007) e101-e104
14. Lin S.J., Schranz J., and Teutsch S.M. Aspergillosis case-fatality rate: systematic review of the literature. Clin. Infect. Dis. 32 (2001) 358-366
15. Lionakis M.S., Lewis R.E., Torres H.A., Albert N.D., Raad I.I., and Kontoyiannis D.P. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn. Microbiol. Infect. Dis. 52 (2005) 15-20
16. Marr K.A., Carter R.A., Boeckh M., Martin P., and Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100 (2002) 4358-4366
17. Marr K.A., Boeckh M., Carter R.A., Kim H.W., and Corey L. Combination antifungal therapy for invasive aspergillosis. Clin. Infect. Dis. 39 (2004) 797-802
18. Perfect J.R., Cox G.M., Lee J.Y., Kauffman C.A., de Repentigny L., Chapman S.W., Morrison V.A., Pappas P., Hiemenz J.W., Stevens D.A., and Mycoses Study Group. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin. Inf. Dis. 33 (2001) 1824-1833
19. Singh N., and Paterson D.L. Aspergillus infection in transplant recipients. Clin. Microbiol. Rev. 18 (2005) 44-69
20. Steinbach W.J., Benjamin Jr. D.K., Kontoyiannis D.P., Perfect J.R., Lutsar I., Marr K.A., Lionakis M.S., Torres H.A., Jafri H., and Walsh T.J. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin. Infect. Dis. 39 (2004) 192-198
21. Trifilio S.M., Bennett C.L., Yarnold P.R., McKoy J.M., Parada J., Mehta J., Chamilos G., Palella F., Kennedy L., Mullane K., Tallman M.S., Evens A., Scheetz M.H., Blum W., and Kontoyiannis D.P. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplantation or intensive chemotherapy. Bone. Marrow. Transplant. 39 (2007) 425-429
22. Varga J., Tóth B., Kocsubé S., Farkas B., Szakács G., Téren J., and Kozakiewicz Z. Evolutionary relationships among Aspergillus terreus isolates and their relatives. Antonie. Van. Leeuwenhoek. 88 (2005) 141-150
23. Wadhwani K., and Srivastava A.K. Fungi from otitis media of agricultural field workers. Mycopathologica 88 (1984) 155-159
24. White T.J., Bruns T., Lee S., and Taylor J.W. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis M.A., Gelfand D.H., Sninsky J.J., and White T.J. (Eds). PCR Protocols: A Guide to Methods and Applications (1990), Academic Press, Inc., New York